A Personal Encounter That Changed Everything
This article began with a personal experience. During a vacation, I was bitten by large mosquitoes and developed a massive, active Lyme infection. Using the frequency analysis methods developed at the Frequency Research Foundation, I went from having difficulty walking due to the crippling effects of the infection to being completely symptom-free in a matter of days.
But the real revelation came after the acute infection was resolved. Experiencing the full range of Lyme symptom patterns during the active infection, I realized something that reframed decades of my own health history: I had carried this infection before — since 1969. For almost 40 years, Lyme had caused chronic back pain, undiagnosed athletic injuries, and various sporadic symptoms that were never attributed to an infectious cause.
This personal experience underscored two critical truths about Lyme disease. First, it can remain chronic and lifelong, producing symptoms that are attributed to other causes for decades. Second, frequency therapy can resolve even severe, acute Lyme infections rapidly when the full constellation of pathogens is addressed.
The Athletic Performance Discovery
One of the most unexpected findings from my Lyme treatment was its effect on physical performance. As soon as I was symptom-free after clearing the acute infection, my two-mile running time decreased by more than 10% compared to my average for the month before the mosquito bites.
A 10% improvement in running performance is enormous. In competitive athletics, it is the difference between placing and not placing, between qualifying and failing to qualify. And this improvement came not from training harder or changing anything about my fitness regimen — it came solely from eliminating an infection I did not know was affecting my performance.
This has direct implications for every runner, cyclist, triathlete, and outdoor athlete. If you train outdoors regularly, your likelihood of Lyme infection is elevated. The infection may be silently compromising your performance even if you feel healthy and are in excellent training. You may be training at 90% of your capacity without knowing it — and attributing the gap to fitness, age, or genetics when the real cause is treatable.
How Widespread Is Lyme Disease?
The standard narrative about Lyme disease dramatically underestimates its prevalence. Based on over two decades of clinical testing at the Frequency Research Foundation, the picture that emerges is far more alarming than official statistics suggest.
What Clinical Testing Reveals
Over 90% of the people Dr. Jeff Sutherland has tested show detectable Lyme frequencies. These infections are typically chronic and lifelong. Most are undiagnosed because symptoms are expressed only when the immune system is depressed through injury, shock, disease episodes, cancer, or other incidents.
Based on these analyses, the Frequency Research Foundation estimates that more than 50% of the entire US population may be infected with the Lyme constellation of pathogens. Many disease syndromes, random symptoms, mysterious diseases, and so-called “psychosomatic” symptoms are actually manifestations of Lyme organisms operating below the threshold of clinical detection.
Official Numbers Keep Rising
Official statistics have steadily moved toward confirming what clinical testing suggested years ago. The CDC now estimates approximately 476,000 new Lyme cases per year in the United States — more than double earlier estimates. Lyme is reported in all 50 states. And these numbers capture only diagnosed cases; the actual number of infected individuals is certainly higher.
Transmission Routes Are Broader Than Acknowledged
The conventional view that Lyme is transmitted exclusively through tick bites does not match the clinical evidence. Research by Dr. Lida Mattman demonstrated recovery of live Borrelia spirochetes from mosquitoes, fleas, mites, semen, urine, blood, and spinal fluid. The Frequency Research Foundation’s clinical experience confirms that mosquito-borne transmission is a significant route — my own acute infection came from mosquito bites, not ticks.
The infected bodily fluids of carriers contain more than half a dozen different parasites, Borrelia, Babesia, Ehrlichia, and other pathogens. While all of them appear to be present in most infections, the majority may never be detected by standard laboratory tests.
The Lyme-Cancer Connection
Every person with cancer that Dr. Jeff Sutherland has tested has shown a Lyme infection. This is a consistent finding across cancer types and patient populations.
The mechanism is biologically plausible. Lyme organisms cause aberration of cells and growth of benign tumors. This means they alter DNA — and an organism that alters DNA is certainly a cofactor in cancer development, in addition to the other diseases associated with Lyme.
This does not mean that Lyme disease causes all cancer. It means that Lyme infection creates cellular conditions — chronic inflammation, immune dysfunction, DNA damage, and disrupted cellular growth regulation — that significantly increase cancer risk. For cancer patients, addressing an underlying Lyme infection may be an important component of comprehensive treatment that is currently being missed by conventional oncology.
Understanding the Full Lyme Complex
Lyme disease is not a single-organism infection. It is a complex of interacting pathogens that must all be addressed for successful treatment.
The Key Organisms
Borrelia burgdorferi spirochetes are the primary pathogen, capable of burrowing into tendons, muscle cells, ligaments, and organs including the brain. Ehrlichia infect white blood cells, compromising immune function from within. Babesia infect red blood cells, causing fatigue, sweats, and anemia-like symptoms — they are particularly difficult to eradicate. Multiple mycoplasma species create chronic fatigue, immune dysfunction, and neurological symptoms. Various parasites serve as reservoirs — they can be infected with other Lyme pathogens, and eliminating parasites can release the Lyme organisms they carry, causing reinfection.
This layered complexity is what makes Lyme disease so challenging. Addressing one pathogen without addressing the others leads to incomplete treatment and symptom recurrence.
The Neurotoxin Problem
Ehrlichia and Borrelia emit neurotoxic proteins that are extremely debilitating. These neurotoxins cause many of the most severe Lyme symptoms — cognitive dysfunction, nerve pain, muscle weakness, and the general feeling of being poisoned.
When eliminating these pathogens with frequencies, it is critical to have frequencies that deactivate the neurotoxins simultaneously. Otherwise, killing the organisms releases a flood of neurotoxins that makes the patient sicker — the classic Lyme Herxheimer effect. This is why many people who attempt Lyme treatment feel worse before they feel better, and why some abandon treatment prematurely.
At the Frequency Research Foundation, Dr. Jeff Sutherland’s protocols include neurotoxin-deactivating frequencies alongside pathogen-targeting frequencies, managing the Herxheimer reaction as an integral part of the treatment rather than an uncontrolled side effect.
The Dormancy Trigger
Lyme organisms can remain dormant for years or decades, kept in check by a functioning immune system. Symptoms emerge when the immune system is compromised by stress, injury, surgery, vaccination reactions, another illness, or aging. This explains why Lyme can appear to strike suddenly in someone who has no memory of a tick bite — they may have been carrying the infection silently for years.
Research has documented cases where symptoms appeared five years or more after the initial infection event. Mycoplasmal co-infections follow the same dormancy-activation pattern, as detailed in our article Mycoplasma: A Key Component in Lyme and Other Diseases.
The Connection to Alzheimer’s and Neurodegenerative Disease
Lyme disease’s ability to invade the brain directly connects it to neurodegenerative conditions including Alzheimer’s disease.
How Lyme Damages the Brain
Borrelia spirochetes can burrow directly into brain tissue, triggering chronic neuroinflammation. The neurotoxic proteins emitted by Borrelia and Ehrlichia cause direct neuronal damage. Mycoplasma co-infections, which cross the blood-brain barrier independently, add additional neuroinflammatory burden. The combined effect is persistent brain inflammation — the same process that drives Alzheimer’s disease progression.
Lyme in Neurodegenerative Disease Patients
Research by Dr. Lida Mattman recovered Borrelia from all tested cases of Alzheimer’s disease, 8 of 8 Parkinson’s cases, 41 multiple sclerosis cases, and 21 ALS cases. Our article Recent Research on Lyme Disease covers these findings in detail, including the remarkable recovery of several terminal ALS patients after appropriate Lyme treatment.
The Multi-Pathogen Theory of Alzheimer’s
Lyme is one component of a broader infectious picture in Alzheimer’s disease. Herpes simplex virus DNA has been found in 90% of Alzheimer’s plaques, as documented in our article Alzheimer’s and Herpes Simplex Virus. Mycoplasma, Borrelia, and viral infections may all contribute to the neuroinflammatory cascade.
For the complete picture of how infections, environmental toxins, nutrition, and frequency therapy all factor into Alzheimer’s disease, read our complete guide to Alzheimer’s disease and frequency therapy.
2026 Update: Two Decades of Clinical Experience
Since this article was first published, the Frequency Research Foundation’s understanding and treatment of Lyme disease has deepened through 20 additional years of clinical observation.
Protocol Evolution
The Lyme frequency protocols have been refined through continuous iteration. Our current protocol, Lyme Frequencies Version 11.0, addresses the full Lyme complex systematically — spirochetes, co-infections, neurotoxins, and parasitic reservoirs — in a sequenced approach that manages Herxheimer reactions throughout. Each version has incorporated new pathogen identifications and more refined frequency targeting.
The Post-COVID Parallel
The COVID-19 pandemic created millions of people with persistent post-infectious symptoms — long COVID — that closely mirror chronic Lyme: fatigue, brain fog, immune dysfunction, exercise intolerance, and chronic pain. This parallel has brought mainstream recognition to the concept that infections can persist and cause chronic illness, making the medical community more receptive to chronic Lyme as a legitimate condition.
Diagnostic Advances
While standard Lyme testing remains inadequate for detecting chronic and co-infections, advances in PCR testing, next-generation sequencing, and other molecular diagnostics have improved the ability to identify Borrelia and co-infections. Frequency-based assessment, as developed by the Frequency Research Foundation, continues to detect infections that laboratory testing misses.
The Chronic Inflammation Framework
The recognition that chronic inflammation drives most chronic disease — from heart disease to cancer to Alzheimer’s — provides a unifying framework for understanding how Lyme disease contributes to so many different conditions. Our article Eliminating Inflammation Is a Top Priority for Disease Prevention covers this foundational principle.
Therapy: The Frequency Approach to Lyme
The Frequency Research Foundation’s approach to Lyme disease therapy differs fundamentally from conventional antibiotic treatment.
Why Antibiotics Are Insufficient
Standard Lyme antibiotics target Borrelia spirochetes in their active, cell-walled form. They do not address cell wall deficient forms that evade antibiotic action, Ehrlichia inside white blood cells, Babesia inside red blood cells, mycoplasma co-infections that lack cell walls entirely, parasites that serve as pathogen reservoirs, or the neurotoxic proteins that cause Herxheimer reactions.
This is why many patients receive multiple rounds of antibiotics yet continue to have symptoms — the antibiotics address only one component of a multi-organism complex.
The Frequency Therapy Advantage
Frequency therapy can target each organism in the Lyme complex with specific frequencies. It can reach organisms inside cells. It can address cell wall deficient forms. Neurotoxin-deactivating frequencies can be applied simultaneously with pathogen-targeting frequencies. Parasitic reservoirs can be cleared to prevent reinfection. The entire complex can be addressed in a coordinated, sequenced protocol.
Dr. Jeff Sutherland’s personal experience — going from difficulty walking to symptom-free in days, followed by a 10% running performance improvement — demonstrates what is possible when the full Lyme complex is addressed comprehensively with frequencies.
Suspect Lyme disease may be affecting your health or performance? Over 90% of people tested at the Frequency Research Foundation show detectable Lyme frequencies. Dr. Jeff Sutherland offers personalized paid consultations to assess your infection status and develop a comprehensive frequency protocol. Book Your Consultation
Frequently Asked Questions
Take the Next Step
Lyme disease is far more common, more complex, and more consequential than conventional medicine acknowledges. Whether you are dealing with chronic unexplained symptoms, a known Lyme diagnosis that has not resolved with treatment, declining athletic performance, or a neurodegenerative condition, the Lyme complex may be a factor.
Dr. Jeff Sutherland has over 20 years of experience developing frequency protocols for the complete Lyme disease complex. A paid consultation can assess your situation and develop a targeted, comprehensive treatment plan.
Book Your Consultation with Dr. Jeff Sutherland
This article is part of our comprehensive Alzheimer’s resource library. Lyme disease and its co-infections contribute to the chronic neuroinflammation that drives Alzheimer’s and other neurodegenerative conditions. Read our complete guide to Alzheimer’s disease and frequency therapy for the full scope of research on infections, toxins, nutrition, and frequency-based treatment.
© Frequency Research Foundation. This content is for educational and informational purposes only. It is not intended to diagnose, treat, cure, or prevent any disease. Always consult with qualified healthcare professionals regarding medical conditions.